Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-40.91%
operating margin TTM
-27.27%
revenue TTM
714.33 Thousand
revenue per share TTM
0.08$
valuation ratios | |
|---|---|
| pe ratio | -12.83 |
| peg ratio | 0.02 |
| price to book ratio | -3.19 |
| price to sales ratio | 3.30 |
| enterprise value multiple | -13.60 |
| price fair value | -3.19 |
profitability ratios | |
|---|---|
| gross profit margin | 96.12% |
| operating profit margin | -27.27% |
| pretax profit margin | -40.78% |
| net profit margin | -40.91% |
| return on assets | -47.34% |
| return on equity | 25.68% |
| return on capital employed | -43.96% |
liquidity ratios | |
|---|---|
| current ratio | 2.16 |
| quick ratio | 2.16 |
| cash ratio | 1.48 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 259.20 |
| cash conversion cycle | -259.20 |
| receivables turnover | 0.00 |
| payables turnover | 1.41 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.50 |
| debt equity ratio | -0.27 |
| long term debt to capitalization | -0.32 |
| total debt to capitalization | -0.37 |
| interest coverage | -1.75 |
| cash flow to debt ratio | -2.56 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.84 |
| cash per share | 0.59 |
| operating cash flow per share | -1.84 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -2.56 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Atara Biotherapeutics, Inc. (NASDAQ:ATRA) reported earnings?
Atara Biotherapeutics, Inc. (ATRA) published its most recent earnings results on 12-05-2026.
What is Atara Biotherapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Atara Biotherapeutics, Inc. (NASDAQ:ATRA)'s trailing twelve months ROE is 25.68%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Atara Biotherapeutics, Inc. (ATRA) currently has a ROA of -47.34%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ATRA's net profit margin stand at?
ATRA reported a profit margin of -40.91% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ATRA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.16 in the most recent quarter. The quick ratio stood at 2.16, with a Debt/Eq ratio of -0.27.